| Bioactivity | Brimarafenibum (Brimarafenib) is a rapidly accelerated fibrosarcoma (Raf) kinase inhibitor, wtih antineoplastic effect[1]. |
| CAS | 1643326-82-2 |
| Formula | C24H17F3N4O4 |
| Molar Mass | 482.41 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Brimarafenibum (Brimarafenib). WHO Drug Information, Vol. 37, No. 4, 2023. |
Brimarafenibum
CAS: 1643326-82-2 F: C24H17F3N4O4 W: 482.41
Brimarafenibum (Brimarafenib) is a rapidly accelerated fibrosarcoma (Raf) kinase inhibitor, wtih antineoplastic effect.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.